Cart
sales@molnova.com
Calenduloside E
CAS No. 26020-14-4
Calenduloside E( —— )
Catalog No. M18321 CAS No. 26020-14-4
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | In Stock |
|
| 10MG | 448 | In Stock |
|
| 25MG | 731 | In Stock |
|
| 50MG | 1017 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCalenduloside E
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
DescriptionCalenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26020-14-4
-
Formula Weight632.83
-
Molecular FormulaC36H56O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (158.02 mM)
-
SMILESCC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)O)C)C)C2C1)C)C(=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matsuda, H., et al.: Chem. Pharma. Bull., 46, 1399 (1998); Matsuda, H., et al.: Biol. Pharma. Bull., 20, 717 (1997)
molnova catalog
related products
-
β-Casomorphin, bovin...
β-Casomorphin, bovine TFA is an opioid peptide isolated from casein peptoneβ-Casomorphin, bovine(beta-casomorphin-7) may contribute significantly to mucin production via a direct effect on intestinal goblet cells and the activation of mu-opioid receptors.?
-
Bevenopran
Bevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
-
ADL5859
ADL5859 is a potent, selective, orally bioavailable full agonist of δ opioid receptor with Ki of 0.84 nM and EC50 of 20 nM.
